FDA Inspection 1047338 — Saving Sight
The FDA completed an inspection of Saving Sight on March 8, 2018 in Springfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 8, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Springfield, MO (United States)